American Well 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Amwell reported third-quarter 2026 revenue of $49 million, down approximately 12.9% year over year and $1 million above the high end of guidance.
- Subscription revenue was $23.9 million, down approximately 22.5% year over year and approximately 6.8% sequentially, reflecting previously disclosed churn.
- Amwell Medical Group visit revenue was $23.7 million, up approximately 11.7% year over year and down approximately 3.1% sequentially; approximately 301,000 paid visits were essentially flat year over year, with revenue per visit of approximately $79, up approximately $8 or 11%.
- Virtual primary care visits increased approximately 41% year over year, while total platform visits were approximately 760,000, down approximately 30.5% year over year.
- Gross profit was $26 million, with a 53% gross margin, up approximately 57 basis points year over year from 52.4% in the third quarter of 2025.
- Operating expenses, including depreciation and amortization, were $37.6 million, down approximately 36.1% year over year; adjusted EBITDA was a loss of $3.6 million versus a loss of $12.7 million in the third quarter of 2025.
- Operating loss was $11.7 million, compared with $29.3 million in the third quarter of 2025, an improvement of approximately 60%.
- Amwell ended the quarter with approximately $181 million in cash and investments and zero debt.
- Management said it had beaten quarterly revenue and adjusted EBITDA guidance, marking nine consecutive quarters of delivering on its commitments.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Hello, everyone, and welcome to Amwell's conference call to discuss their third fiscal quarter of 2026. Joining us on the call today are Amwell's Chairman and CEO, Dr. Ido Schoenberg, and Mark Hirschhorn, Amwell's CFO and Chief Operating Officer. Earlier today, a press release was distributed detailing their announcement. The earnings report is posted on the Amwell website at investors.amwell.com and is also available through normal news sources. This conference call is being webcast live on the IR page of the website, where the replay will be archived. Before they begin prepared remarks, I would like to take this opportunity to remind you that during the call, we will make forward-looking statements regarding projected operating results and anticipated market opportunities. This forward-looking information is subject to the risks and uncertainties described in the filings with the SEC. Actual results or events may differ materially.
Except as required by law, we undertake no obligation to update or revise these forward-looking statements. On this call, we will refer to both the GAAP and non-GAAP financial measures. A reconciliation of GAAP and non-GAAP financial measures is provided in the earnings release. With that, I would like to turn the call over to Ido.
Good evening, and thank you for joining our third quarter earnings call. This was another quarter of steady progress. We set a goal at the start of the year: reach positive cash flow from operations and positive adjusted EBITDA in the fourth quarter and build from there. We beat our guidance for the quarter on both revenue and adjusted EBITDA. That makes nine quarters in a row of delivering our commitments to you. We are pleased with the quarter and with our progress across the business, and we have good visibility to that fourth quarter goal. Mark will take you through the numbers. Before he does, let me cover our market, our product, and recent developments in our company. Let me start with our customers, because their reality shapes everything we do. Health plans and employers face their largest cost increases in about two decades.
Costs are projected to rise another 8%-11% in 2027. Last month, UnitedHealth said costs remain stubbornly high across the entire healthcare landscape. Premiums are not keeping pace. The easy fixes are gone. Technology-enabled care is one of the few levers left, but only if it comes with proof. That pressure is changing how health plans and employers buy. They no longer buy access. They buy engagement and outcomes. Most now tie digital health fees to performance. Nearly half of them say the programs they buy enroll fewer than one in four eligible members. Poor engagement is now the top reason they switch vendors. Health plans and employers face three major challenges in digital health today. The first is vendor sprawl, dozens of point solutions, each with its own front door, costly to connect, and hard to compare. The second is member confusion.
A member who does not know where to start does not start. The third is the lack of proof. It is hard to see which programs work and harder still to replace one without disrupting members. That sprawl is accelerating. AI has made it faster and cheaper to build a clinical program. Investors have backed hundreds of new digital health companies this year, many of them built on AI. Our customers feel pressure to offer these programs, but each one brings its own cost, its own integration, and its own front door. The opportunity is real. So is the complexity. More and more, a member's journey to care begins in a conversation with an AI assistant. Three in 10 adults now use AI tools for health information at least once a month, up from about one in six two years ago.
The question for our customers is where that conversation ends. It can end with a guess. It can end with care that is wrong for the member and wasteful for the plan, or it can end with a covered in-network service that fits the member's need and has proven clinical and financial outcomes. This is the problem Amwell is determined to solve for our customers. We help them improve clinical and financial outcomes. We do it through activation, getting more of their members into technology-enabled care in place of conventional care that often costs more. We give our customers one platform under their brand with one integration. It provides reliable, scalable rails to bring in a program, exchange data with it, and tests whether it works. The member's experience stays consistent, simple, and engaging. A common data structure proves the outcomes and improves performance over time.
As AI begins to transform healthcare, this platform becomes even more necessary. We are not selling an AI feature. We are the trusted platform where AI-powered care runs with clinicians in the loop. We extend our clients. We never compete with them. That is why large and sophisticated organizations trust us with their members. Our customers together represent more than 90 million covered lives. We serve the 9.6 million beneficiaries of the Military Health System, and the Department of Veterans Affairs has signaled its intent to do the same. Two recent recognitions point the same way. In September, Frost & Sullivan recognized Amwell for technology innovation leadership. It cited our ability to address healthcare fragmentation through a unified platform. Time magazine named Amwell to its list of the world's top health tech companies of 2026. Let me be specific about where we are focused for our customers today.
There are six areas, and all six run on the platform I just described. Three are about the member, getting members in, what they see, and keeping them. Two are about the programs, our partners and our own. The last is the data that proves what works. For each, I will describe the problem and what we do about it today. First, activation. A customer gets value only when its members use the care it has bought. Most of the health plans we talk to still see engagement in the single digits. We address that with always-on engagement, outreach to members through our customers' own channels within the rules they set. When a customer switches it fully on, members use the platform at more than three times the rate we see when it's off. Activation is where value begins. Without it, nothing else happens.
With it, members get care, our customers get results, and we grow. Second, the member experience. This quarter, we shipped a dramatically improved experience to most of our key customers. Returning members now see three screens instead of 12. Members rate their visits 4.9 out of five. Behind that experience are the clinicians of the Amwell Medical Group. They provide urgent care, virtual primary care, and behavioral health, as well as nutrition and lactation programs. They are also empathetic guides through a confusing system. They help the member decide where to go next, and they are a steady source of confidence, simplicity, and a personal connection to a clinician. That is the experience we deliver. Third, the member's ongoing relationship with a clinician. Today, most virtual care ends when the visit ends.
We invest in what happens before and after the visit, so the relationship is durable and the member has a reason to come back. That matters to our customers because the clinician the member trusts is an effective referral point into the programs the customer has chosen. That is how activation compounds. Fourth, choice. This is where the programs come in. The member should get the right program, not just the available one. Our standard process brings a partner program live in weeks. One sign-on, one eligibility file, one data connection, one report under the customer's brand. Our customers can add a program or replace one without disrupting members. That is choice without the sprawl. Fifth, behavioral health, where demand keeps rising and supply keeps falling short. SilverCloud is our behavioral health module on the Amwell platform.
It automates the delivery of evidence-based care, and it gives members a path to our own therapists and psychiatrists on the same platform. The evidence is building. Last month, we published a case study with Discovery Health, one of South Africa's largest health plans. In its first 12 months, the program activated 22,000 members. 90% of surveyed users were satisfied. Among members with moderate to severe depression, 60%-78% showed clinically significant improvement. And in the year after use, members' hospital costs related to mental health were 6% lower after adjusting for other factors. Activation first, with measured outcomes behind it. We prove, we do not claim. Sixth and last, data. A common data structure runs under everything I have described. It sends a member into a program with the right information.
It collects outcomes back, and it reports value in the customer's own terms, whether that customer is a health plan or an employer that the plan serves. That is how a program proves its return on investment and how it gets better over time. Six areas, one platform. Together, they answer the three challenges I started with: vendor sprawl, member confusion, and the lack of proof. That is where we are focused for our customers today and where we will keep investing. Let me turn to our government business, starting with the Department of Veterans Affairs. In September, we announced the department issued a letter of intent for us to deploy the Amwell platform across its enterprise. The department serves more than 9 million veterans. I want to be precise about what this is. The letter is not a binding contract.
A definitive agreement still has to be negotiated and executed under federal procurement rules, and that work is underway. The letter followed a comprehensive evaluation. It cited scalable video consultations, interoperability, cybersecurity compliance, and support for integrated care delivery. In plain terms, the capabilities the Department evaluated are the ones we already run at scale for the Military Health System, and the Department's own scale is considerable. In fiscal 2025, more than 2.9 million veterans used its telehealth services, and it delivered more than 11.7 million video visits to the home. We are honored by that trust, and we are preparing for this work deliberately. With the Defense Health Agency, we continue to serve the Military Health System without interruption. We are negotiating the direct, longer-term contract that the agency signaled its intent to award in June. Before I close, two principles guide how we run the company.
The first is discipline. We are determined to keep improving efficiency and effectiveness across the business. We hold ourselves to the same standard we offer our customers. We measure results before we claim them. The second is focus. We are simplifying our efforts around a single differentiated Amwell platform. One platform is more reliable for our customers, faster to extend, and less expensive to run. It is what makes everything I described possible. To sum up, the market is moving towards what we've built. AI is multiplying the programs our customers can offer. Our platform is the reliable way to bring those programs to members and to prove which ones work. Virtual care for the Military Health System runs on it. The Department of Veterans Affairs has signaled its intent to follow, and we are doing all of this with discipline.
We have good visibility to positive cash flow from operations and positive adjusted EBITDA in the fourth quarter. With that, I will turn the call over to Mark, who will walk you through our operational and financial results.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
9 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
